| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/01/2002 | US20020100185 Drying method for selectively removing volatile components from wet coatings |
| 08/01/2002 | DE10103158A1 Vorrichtung zur elektrisch unterstützen Abgabe von Wirkstoffen aus flächenförmigen therapeutischen Systemen Apparatus for electrically assisted delivery of drugs from planar therapeutic systems |
| 08/01/2002 | DE10102817A1 Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen Apparatus and method for heat pulse-assisted transdermal application of active substances |
| 08/01/2002 | DE10102229A1 Torfproduktzusammensetzung, Verfahren zu deren Herstellung und Verwendung derselben Torfproduktzusammensetzung, processes for their preparation and use thereof |
| 08/01/2002 | DE10101307A1 Fumarsäurederivate als NF-kappaB-Inhibitor Fumaric acid derivatives as NF-kappaB inhibitor |
| 08/01/2002 | CA2442602A1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 08/01/2002 | CA2436076A1 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435876A1 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | CA2435573A1 Alkyl aryl polyether alcohol polymers for improvement of nasal breathing |
| 08/01/2002 | CA2435418A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | CA2435415A1 Microparticles of biodegradable polymer encapsulating a biologically active substance |
| 08/01/2002 | CA2435410A1 Systemic formulations containing beta-carotene and derivatives thereof |
| 08/01/2002 | CA2435124A1 Formulation of boronic acid compounds |
| 08/01/2002 | CA2434765A1 Degradation-resistant glucocorticosteroid formulations |
| 08/01/2002 | CA2434584A1 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
| 08/01/2002 | CA2434226A1 Process for preparing non-hygroscopic sodium valproate composition |
| 08/01/2002 | CA2433838A1 Process for preparing particles |
| 08/01/2002 | CA2433834A1 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | CA2433530A1 New film coating |
| 08/01/2002 | CA2433528A1 Improved process for the production of sustained release drug delivery devices |
| 08/01/2002 | CA2432096A1 Methods for preparing purified lipopeptides |
| 07/31/2002 | EP1227088A1 Crystalline base of citalopram and hydrochoride or hydrobromide salt thereof |
| 07/31/2002 | EP1226864A1 A stable water-in-oil-in-water multiple emulsion system by hydrodynamic dual stabilization and a method for preparation thereof |
| 07/31/2002 | EP1226832A2 Preparation of further diagnostic agents |
| 07/31/2002 | EP1226831A1 Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts |
| 07/31/2002 | EP1226829A2 Stabilised liquid preparations of the protease or its proenzyme which activitate the blood coagulation factor VII |
| 07/31/2002 | EP1226818A1 Pharmaceutical dosage forms with enhanced cohesive and compressibility properties |
| 07/31/2002 | EP1226438A1 Composite nanospheres and their conjugates with biomolecules |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226232A2 Synthetic substrate for tissue formation |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226212A1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225956A1 Method and compositions for administering taxanes orally to human patients |
| 07/31/2002 | EP1225951A2 A dual adhesive transdermal drug delivery system |
| 07/31/2002 | EP1225950A1 Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof |
| 07/31/2002 | EP1225929A2 A polymer micelle as monolayer or layer-laminated surface |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225916A1 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing |
| 07/31/2002 | EP1225912A1 A method of prophylaxis and treatment |
| 07/31/2002 | EP1225905A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 07/31/2002 | EP1225902A1 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225898A2 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 07/31/2002 | EP1225897A2 Composition for treatment of constipation and irritable bowel syndrome |
| 07/31/2002 | EP1225888A2 Sustained-release formulations for treating cns-mediated disorders |
| 07/31/2002 | EP1225887A2 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP1225884A1 Method for administering a phosphodiesterase 4 inhibitor |
| 07/31/2002 | EP1225880A2 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 07/31/2002 | EP1225879A2 Ophthalmic formulation of dopamine antagonists |
| 07/31/2002 | EP1225876A2 Gastroresistant tablets for alimentary, dietetic and therapeutic use |
| 07/31/2002 | EP1225875A2 Apparatus and process for preparing crystalline particles |
| 07/31/2002 | EP1225874A1 Antiviral compositions |
| 07/31/2002 | EP1225873A2 Amphiphilic polymeric vesicles |
| 07/31/2002 | EP1225872A1 New and improved formulation for paclitaxel |
| 07/31/2002 | EP1225871A2 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 07/31/2002 | EP1225870A1 Composition and method of cancer antigen immunotherapy |
| 07/31/2002 | EP1225813A1 Cholesterol reducing stanol compositions, preparation and method of use |
| 07/31/2002 | EP1225812A2 Cholesterol reducing sterol compositions, preparation and method of use |
| 07/31/2002 | EP1225810A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 07/31/2002 | EP1225809A2 Methods for stabilizing liquid nutritional products and products so stabilized |
| 07/31/2002 | EP1158964A4 Edible coating composition |
| 07/31/2002 | EP1035889B1 Device for enhancing transdermal agent flux |
| 07/31/2002 | EP0914095B1 Method for fabricating polymer-based controlled-release devices |
| 07/31/2002 | EP0862421B1 Prompt-release pharmaceutical compositions |
| 07/31/2002 | EP0858325B1 Stable freeze-dried pharmaceutical formulation |
| 07/31/2002 | EP0825848B1 Translucent collagen formulations |
| 07/31/2002 | EP0824356B1 Pharmaceutical compositions for the treatment of alcohol addiction |
| 07/31/2002 | EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 07/31/2002 | EP0799047B1 Viscous liquid conditioning topical germicides |
| 07/31/2002 | EP0760650B1 Antimicrobial oil-in-water emulsions |
| 07/31/2002 | EP0759743B1 Emulsion comprising a gelled aqueous outer phase, a non-aqueous intermediate phase and an aqueous inner phase |
| 07/31/2002 | EP0731699B1 Method of reducing body fat in animals by the administration of conjugated linoleic acid |
| 07/31/2002 | EP0721332B1 Process ii |
| 07/31/2002 | CN2502674Y Adhesive plaster for dilating nasal cavity breathing |
| 07/31/2002 | CN1361806A Pullulan film compositions |
| 07/31/2002 | CN1361789A Rapid dehydration of proteins |
| 07/31/2002 | CN1361785A Titanium derived compounds, preparation and use thereof |
| 07/31/2002 | CN1361694A Glycyrrhizin preparations for transmucosal absorption |
| 07/31/2002 | CN1361690A Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 07/31/2002 | CN1361689A Stable xylometazoline and oxymetazoline solution |
| 07/31/2002 | CN1361686A Percutaneously absorbable preparations |
| 07/31/2002 | CN1361685A Sustained release compositions, process for producing the same and use thereof |
| 07/31/2002 | CN1361684A Biodegradable poly (alkylene oxide)-poly cp-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 07/31/2002 | CN1361683A Novel preparation and administration form comprising an acid-labile active compound |
| 07/31/2002 | CN1361682A A liposome composition having resistance to freeze/thaw damage |
| 07/31/2002 | CN1361681A Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/31/2002 | CN1361680A Use of at least one extract of aplant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 07/31/2002 | CN1361677A Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/31/2002 | CN1361666A Cactus fruit health products |
| 07/31/2002 | CN1360943A Chinese medicine prepn with functions of resisting senility, resisting fatigue and treating women's asexuality |
| 07/31/2002 | CN1360941A Nanometer women's Qianjin Medicine and its prepn |
| 07/31/2002 | CN1360940A Nanometer psoriasis-treating medicine and its prepn |
| 07/31/2002 | CN1360939A Nanometer eyesight-improving and health-clearing medicine and its prepn |
| 07/31/2002 | CN1360938A Nanometer rhinitis-treaitng Qianbai medicine and its prepn |